reference/20896838

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/20896838

Outgoing Links

Predicate	Object
contentType	Journal Article
endingPage	e27
issn	2352-3026
issueIdentifier	1
pageRange	e17-e27
publicationName	The Lancet. Haematology
startingPage	e17
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_ef5a7743327a74b51f7a23e94a8307c1 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_53dc03c9f43d284fe29a4e70d632a064
bibliographicCitation	Trotman J, Luminari S, Boussetta S, Versari A, Dupuis J, Tychyj C, Marcheselli L, Berriolo-Riedinger A, Franceschetto A, Julian A, Ricard F, Guerra L, Haioun C, Biasoli I, Tilly H, Federico M, Salles G, Meignan M. Prognostic value of PET-CT after first-line therapy in patients with follicular lymphoma: a pooled analysis of central scan review in three multicentre studies. Lancet Haematol. 2014 Oct;1(1):e17–27. doi: 10.1016/s2352-3026(14)70008-0. PMID: 27030064.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e0afaf64eeec00baa9dbf18eb711dd51 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6597853ec76d3f44d563d45a2fbabb5a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a3c1a31a84ad3725c4b50a43a94a2a16 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-1287-8075 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2be99fce76148a6e9b9e4f89071ab4ce http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_96ed0e3378b6bdc00cf5a9d9f4de6679 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7cf1e142aaefd41cc1cc280ad353eaad http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e74d53c43378236ef7fa278d60b0b8b8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-9541-8666 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_554c89ccac3b8fac556c4b7e32065b01 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_239309cc5dea4c2f54660c08b0e00b28 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6bf3d176bf27d3baed9fc02564a17ce7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1f9c02a947a702ff6acf8575c6b8dc45 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c056e92a26c04784ca2b0a8a08332f9e http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-7265-7691 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-0095-5379 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0f5a945d46ae4e114d5709e22c4768e0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_de8b25993dccf3fc993dcf7070c6d8c6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1531acdf17ca06170fa44dee98bec07b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_909f2f89c7a40b25b9bbfff8d2632bf1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7a4964432b561515ff90e4b782ad1c72 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4f9b67a92b91b53b36ccd8880fcef234
date	201410
identifier	https://doi.org/10.1016/s2352-3026%2814%2970008-0 https://pubmed.ncbi.nlm.nih.gov/27030064
isPartOf	https://portal.issn.org/resource/ISSN/2352-3026 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/43133
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Prognostic value of PET-CT after first-line therapy in patients with follicular lymphoma: a pooled analysis of central scan review in three multicentre studies
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11469444 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8389 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8388 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID450503

Showing number of triples: 1 to 46 of 46.